Sponsor:
Abramson Cancer Center at Penn Medicine
Code:
NCT06870617
Conditions
Geriatric Assessment
Advanced Cancer
Toxicity
Eligibility Criteria
Sex: All
Age: 70+
Healthy Volunteers: Not accepted
Interventions
Practical Geriatric Assessment
Correlation of body composition PGA and step count with outcomes
Brief summary:
Conditions
Geriatric Assessment
Advanced Cancer
Toxicity
Study ID
NCT06870617
Start date
Jul 1, 2025
Status verified date
Aug, 2026
Completion date
Oct 1, 2026
Anticipated
Primary completion date
Oct 1, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 70+
Healthy Volunteers: Not accepted
Enrollment
150 participants
Anticipated
Arms
PGA Implementation Cohort (n=150)
Correlative analyses cohort (n=100)
Interventions
Practical Geriatric Assessment
Correlation of body composition PGA and step count with outcomes
Primary outcome measure
Central contacts
Locations
Penn Medicine Princeton Medical Center
Recruiting
Princeton, New Jersey, United States, 08540
Contacts
Pennsylvania Hospital
Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contacts
Sponsor
Abramson Cancer Center at Penn Medicine
Last update posted
Aug 6, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2026-08-06.